Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX).

Vincent, Jean-Louis

Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX). [electronic resource] - Critical care medicine Jan 2015 - 57-64 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1530-0293

10.1097/CCM.0000000000000554 doi


Adult
Aged
Aged, 80 and over
Female
Hemoglobins--therapeutic use
Humans
Length of Stay--statistics & numerical data
Male
Middle Aged
Nitric Oxide--antagonists & inhibitors
Polyethylene Glycols--therapeutic use
Respiration, Artificial--statistics & numerical data
Shock--drug therapy
Survival Analysis
Young Adult